10x Genomics, Fred Hutch launch clinical research collaboration on single-cell, spatial oncology applications

Bitget2026/10/07 13:02

10x Genomics launched a clinical research collaboration with Fred Hutch to extend its oncology evidence base into blood cancers. Bladder cancer work will study whether single-cell and spatial readouts can predict treatment response, aiming to support future therapy selection. A separate acute myeloid leukemia project will test whether single-cell analysis can improve residual disease detection versus today’s fragmented approach. No clinical results were reported; findings are expected in future readouts as the studies progress. Effort supports groundwork for potential diagnostic use, including a clinical reporting framework tied to 10x’s planned CLIA-certified lab. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610070900PR_NEWS_USPR_____LA65153) on October 07, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Needham raises CrowdStrike target price to $310

格隆汇•2026/10/10 08:39

Citi: French fiscal risks may cause ECB to pause rate hikes after December, euro likely to drop below 1.10

华尔街见闻•2026/10/10 07:43

Morgan Stanley raises CME Group price target to $337

格隆汇•2026/10/10 07:37

Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories

Chaincatcher•2026/10/10 07:19